Need to get away from bs trading, NUGX -OTC-pinksheets etc. If NUGX is guidance for IPO interest it appears very little excitement. Valuation of 500M looks low , 300M has been around forever excluding Merck deal so what happened ..........Merck + company + possible vaccine currently 200M???? Unless successful roadshow and major institutional support any GNBT/NGIO calculations are not realistic!! With possible vaccine issues ahead a complete vaccine should have major mainstream exposure .........any professional PR firm in the works??
Volume and stability necessary to absorb upcoming selling !! Communication remains a big issue!!